AstraZeneca: Should You Buy, Sell or Hold AstraZeneca Stock Before Q1 Earnings?
AZN's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, are expected to have driven the company's top line.
Read full article »
CEO
Pascal Soriot
AstraZeneca is an England-based biopharmaceutical company that researches and develops prescription medicines for the treatment of cancer and renal diseases.
Read more